INVO Fertility financials
$0.9110−2.42%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 |
|---|---|---|---|---|---|
| Revenue | $2.2M | $2.0M | $1.6M | $1.8M | $1.9M |
| Gross profit | $762.7K | $727.8K | $536.9K | $629.3K | $770.1K |
| Gross margin | 35.1% | 36.1% | 33.9% | 35.8% | 41.3% |
| Operating income | -$1.3M | -$1.6M | -$1.4M | -$1.6M | -$3.0M |
| Net income | $888.7K | -$5.5M | $202.8K | -$2.6M | -$3.6M |
| Net margin | 40.9% | −274.9% | 12.8% | −150.5% | −194.2% |
| Diluted EPS | $0.35 | $-3.38 | — | $-0.77 | $-364.23 |
| EBITDA | -$1.1M | -$1.4M | -$1.3M | -$1.5M | -$1.4M |
| Operating cash flow | -$1.1M | -$1.9M | $25.2K | -$1.8M | -$1.7M |
| Free cash flow | -$1.1M | -$1.9M | $13.4K | -$1.8M | -$1.7M |
| Diluted shares | 2.6M | 1.6M | — | 3.4M | 0.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 |
|---|---|---|---|---|---|
| Cash & equivalents | $3.7M | $4.9M | $2.1M | $355.9K | $549.2K |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $1.6M | $1.0M | $2.0M | $1.1M | $3.9M |
| Total assets | $25.8M | $24.7M | $20.2M | $18.8M | $19.3M |
| Total liabilities | $9.3M | $9.6M | $13.0M | $13.0M | $16.7M |
| Shareholders' equity | $16.5M | $15.0M | $7.2M | $5.8M | $2.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology